PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,299 | +15248.1% | 9,910 | +25310.3% | 0.00% | – |
| Q2 2023 | $1,077 | -88.0% | 39 | -96.5% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 1,112 | +136.6% | 0.00% | – |
| Q1 2022 | $11,000 | +10.0% | 470 | +69.1% | 0.00% | – |
| Q4 2021 | $10,000 | +150.0% | 278 | +5.3% | 0.00% | – |
| Q3 2021 | $4,000 | -75.0% | 264 | -25.6% | 0.00% | – |
| Q2 2021 | $16,000 | +77.8% | 355 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 355 | -17.1% | 0.00% | – |
| Q4 2020 | $9,000 | +800.0% | 428 | +601.6% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |